Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-04-01

AUTHORS

I Chau, M Allen, D Cunningham, D Tait, G Brown, M Hill, K Sumpter, A Rhodes, A Wotherspoon, A R Norman, A Hill, A Massey, Y Prior

ABSTRACT

This study was designed to evaluate the benefits of neoadjuvant chemotherapy prior to chemoradiation and surgery in patients with locally advanced rectal cancer. Patients with previously untreated primary rectal cancer, reviewed in a multidisciplinary meeting and considered to have locally advanced disease on the basis of physical examination and imaging (MRI+CT n=30, CT alone n=6), were recruited. Patients received protracted venous infusion 5-FU (300 mg m−2 day−1 for 12 weeks) with mitomycin C (MMC) (7 mg m−2 i.v. bolus every 6 weeks). Starting on week 13, 5-FU was reduced to 200 mg m−2 day−1 and concomitant pelvic radiotherapy 45 Gy in 25 fractions was commenced followed by 5.4–9 Gy boost to tumour bed. Surgery was planned 6 weeks after chemoradiation. Postoperatively, patients received 12 weeks of MMC and 5-FU at the same preoperative doses. Between January 99 and August 01, 36 eligible patients were recruited. Median age was 63 years (range=40–85). Following neoadjuvant chemotherapy, radiological tumour response was 27.8% (one CR and nine PRs) and no patient had progressive disease. In addition, 65% of patients had a symptomatic response including improvement in diarrhoea/constipation (59%), reduced rectal bleeding (60%) and diminished pelvic pain/tenesmus (78%). Following chemoradiation, tumour regression occurred in 80.6% (six CRs and 23 PRs; 95% CI=64–91.8%) and only one patient still had an inoperable tumour. R0 resection was achieved in 28 patients (82%). When compared with initial clinical staging, the pathological downstaging rate in T and/or N stage was 73.5% and pathological CR was found in one patient. Neoadjuvant systemic chemotherapy as a prelude to synchronous chemoradiation can be administered with negligible risk of disease progression and produces considerable symptomatic response with associated tumour regression. More... »

PAGES

1017-1024

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6600822

DOI

http://dx.doi.org/10.1038/sj.bjc.6600822

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1004258740

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12671697


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitomycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rectal Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chau", 
        "givenName": "I", 
        "id": "sg:person.01035560774.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035560774.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Allen", 
        "givenName": "M", 
        "id": "sg:person.01054213150.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054213150.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cunningham", 
        "givenName": "D", 
        "id": "sg:person.01320161130.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiotherapy, Royal Marsden Hospital, London Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Radiotherapy, Royal Marsden Hospital, London Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tait", 
        "givenName": "D", 
        "id": "sg:person.0753037103.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Imaging, Royal Marsden Hospital, London Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Diagnostic Imaging, Royal Marsden Hospital, London Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "G", 
        "id": "sg:person.01265153477.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265153477.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hill", 
        "givenName": "M", 
        "id": "sg:person.01277776673.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277776673.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sumpter", 
        "givenName": "K", 
        "id": "sg:person.0701422002.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701422002.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Imaging, Royal Marsden Hospital, London Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Diagnostic Imaging, Royal Marsden Hospital, London Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rhodes", 
        "givenName": "A", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Histopathology, Royal Marsden Hospital, London Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Histopathology, Royal Marsden Hospital, London Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wotherspoon", 
        "givenName": "A", 
        "id": "sg:person.01000107664.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000107664.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Computing, Royal Marsden Hospital, London Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Computing, Royal Marsden Hospital, London Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Norman", 
        "givenName": "A R", 
        "id": "sg:person.012011726757.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011726757.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hill", 
        "givenName": "A", 
        "id": "sg:person.01027613160.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027613160.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Massey", 
        "givenName": "A", 
        "id": "sg:person.0624374163.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624374163.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prior", 
        "givenName": "Y", 
        "id": "sg:person.01332431220.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332431220.96"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s000660050051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043048801", 
          "https://doi.org/10.1007/s000660050051"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00002396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021451694", 
          "https://doi.org/10.1007/pl00002396"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-04-01", 
    "datePublishedReg": "2003-04-01", 
    "description": "This study was designed to evaluate the benefits of neoadjuvant chemotherapy prior to chemoradiation and surgery in patients with locally advanced rectal cancer. Patients with previously untreated primary rectal cancer, reviewed in a multidisciplinary meeting and considered to have locally advanced disease on the basis of physical examination and imaging (MRI+CT n=30, CT alone n=6), were recruited. Patients received protracted venous infusion 5-FU (300\u2009mg\u2009m\u22122\u2009day\u22121 for 12 weeks) with mitomycin C (MMC) (7\u2009mg\u2009m\u22122 i.v. bolus every 6 weeks). Starting on week 13, 5-FU was reduced to 200\u2009mg\u2009m\u22122\u2009day\u22121 and concomitant pelvic radiotherapy 45\u2009Gy in 25 fractions was commenced followed by 5.4\u20139\u2009Gy boost to tumour bed. Surgery was planned 6 weeks after chemoradiation. Postoperatively, patients received 12 weeks of MMC and 5-FU at the same preoperative doses. Between January 99 and August 01, 36 eligible patients were recruited. Median age was 63 years (range=40\u201385). Following neoadjuvant chemotherapy, radiological tumour response was 27.8% (one CR and nine PRs) and no patient had progressive disease. In addition, 65% of patients had a symptomatic response including improvement in diarrhoea/constipation (59%), reduced rectal bleeding (60%) and diminished pelvic pain/tenesmus (78%). Following chemoradiation, tumour regression occurred in 80.6% (six CRs and 23 PRs; 95% CI=64\u201391.8%) and only one patient still had an inoperable tumour. R0 resection was achieved in 28 patients (82%). When compared with initial clinical staging, the pathological downstaging rate in T and/or N stage was 73.5% and pathological CR was found in one patient. Neoadjuvant systemic chemotherapy as a prelude to synchronous chemoradiation can be administered with negligible risk of disease progression and produces considerable symptomatic response with associated tumour regression.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6600822", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "88"
      }
    ], 
    "keywords": [
      "advanced rectal cancer", 
      "rectal cancer", 
      "mitomycin C", 
      "neoadjuvant chemotherapy", 
      "symptomatic response", 
      "tumor regression", 
      "synchronous chemoradiation", 
      "diarrhea/constipation", 
      "initial clinical staging", 
      "pathological downstaging rate", 
      "neoadjuvant systemic chemotherapy", 
      "radiological tumor response", 
      "primary rectal cancer", 
      "radiotherapy 45", 
      "preoperative doses", 
      "eligible patients", 
      "systemic fluorouracil", 
      "advanced disease", 
      "rectal bleeding", 
      "R0 resection", 
      "systemic chemotherapy", 
      "progressive disease", 
      "pathological CR", 
      "median age", 
      "clinical staging", 
      "physical examination", 
      "venous infusion", 
      "tumor response", 
      "inoperable tumors", 
      "disease progression", 
      "multidisciplinary meeting", 
      "chemoradiation", 
      "week 13", 
      "patients", 
      "chemotherapy", 
      "cancer", 
      "surgery", 
      "negligible risk", 
      "disease", 
      "weeks", 
      "constipation", 
      "tenesmus", 
      "bleeding", 
      "resection", 
      "response", 
      "fluorouracil", 
      "regression", 
      "effective strategy", 
      "infusion", 
      "tumors", 
      "staging", 
      "doses", 
      "progression", 
      "age", 
      "risk", 
      "examination", 
      "imaging", 
      "years", 
      "study", 
      "benefits", 
      "rate", 
      "improvement", 
      "meeting", 
      "boost", 
      "stage", 
      "addition", 
      "strategies", 
      "fraction", 
      "bed", 
      "prelude", 
      "basis", 
      "Cr"
    ], 
    "name": "Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer", 
    "pagination": "1017-1024", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1004258740"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6600822"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12671697"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6600822", 
      "https://app.dimensions.ai/details/publication/pub.1004258740"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_377.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6600822"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600822'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600822'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600822'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600822'


 

This table displays all metadata directly associated to this object as RDF triples.

288 TRIPLES      21 PREDICATES      113 URIs      103 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6600822 schema:about N14cd41371d8646498972c377c219a668
2 N269fa8d4fdca4243b231c478e8bc2b66
3 N2c63c993c656407db80f8e68eac4427b
4 N5444782eba4e470e8a76d24f79eed09d
5 N63065a6af42b4cf6ab501233d9dfd93d
6 N7954a039fbf64a649a662cad66a29665
7 N80019e3947d344a98baa5f22fc531fb3
8 N90f65507bfeb430d8e944ceb36f9396d
9 Na5add7ffa0ac44c88dfb2f0a1d8fafcb
10 Nb255dedd05d745d8bbdf8d27a2e56cbb
11 Nc75a32a4d4ee4773801c4bdbd1e89743
12 Nd62abebd96e54df5a9e20d7b453f4967
13 Nead7f75c7a93415d80e31c2bc1cc0b98
14 Nfa15daaf626b4430b7b9265e1e6c1d60
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N9a85e1a51be0413a9c002e046a25d24e
18 schema:citation sg:pub.10.1007/pl00002396
19 sg:pub.10.1007/s000660050051
20 schema:datePublished 2003-04-01
21 schema:datePublishedReg 2003-04-01
22 schema:description This study was designed to evaluate the benefits of neoadjuvant chemotherapy prior to chemoradiation and surgery in patients with locally advanced rectal cancer. Patients with previously untreated primary rectal cancer, reviewed in a multidisciplinary meeting and considered to have locally advanced disease on the basis of physical examination and imaging (MRI+CT n=30, CT alone n=6), were recruited. Patients received protracted venous infusion 5-FU (300 mg m−2 day−1 for 12 weeks) with mitomycin C (MMC) (7 mg m−2 i.v. bolus every 6 weeks). Starting on week 13, 5-FU was reduced to 200 mg m−2 day−1 and concomitant pelvic radiotherapy 45 Gy in 25 fractions was commenced followed by 5.4–9 Gy boost to tumour bed. Surgery was planned 6 weeks after chemoradiation. Postoperatively, patients received 12 weeks of MMC and 5-FU at the same preoperative doses. Between January 99 and August 01, 36 eligible patients were recruited. Median age was 63 years (range=40–85). Following neoadjuvant chemotherapy, radiological tumour response was 27.8% (one CR and nine PRs) and no patient had progressive disease. In addition, 65% of patients had a symptomatic response including improvement in diarrhoea/constipation (59%), reduced rectal bleeding (60%) and diminished pelvic pain/tenesmus (78%). Following chemoradiation, tumour regression occurred in 80.6% (six CRs and 23 PRs; 95% CI=64–91.8%) and only one patient still had an inoperable tumour. R0 resection was achieved in 28 patients (82%). When compared with initial clinical staging, the pathological downstaging rate in T and/or N stage was 73.5% and pathological CR was found in one patient. Neoadjuvant systemic chemotherapy as a prelude to synchronous chemoradiation can be administered with negligible risk of disease progression and produces considerable symptomatic response with associated tumour regression.
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N1f4b51c08ca6486ea08ee287c44a30b4
26 Nb645f67b69cb4a958b647e187ea3471d
27 sg:journal.1017082
28 schema:keywords Cr
29 R0 resection
30 addition
31 advanced disease
32 advanced rectal cancer
33 age
34 basis
35 bed
36 benefits
37 bleeding
38 boost
39 cancer
40 chemoradiation
41 chemotherapy
42 clinical staging
43 constipation
44 diarrhea/constipation
45 disease
46 disease progression
47 doses
48 effective strategy
49 eligible patients
50 examination
51 fluorouracil
52 fraction
53 imaging
54 improvement
55 infusion
56 initial clinical staging
57 inoperable tumors
58 median age
59 meeting
60 mitomycin C
61 multidisciplinary meeting
62 negligible risk
63 neoadjuvant chemotherapy
64 neoadjuvant systemic chemotherapy
65 pathological CR
66 pathological downstaging rate
67 patients
68 physical examination
69 prelude
70 preoperative doses
71 primary rectal cancer
72 progression
73 progressive disease
74 radiological tumor response
75 radiotherapy 45
76 rate
77 rectal bleeding
78 rectal cancer
79 regression
80 resection
81 response
82 risk
83 stage
84 staging
85 strategies
86 study
87 surgery
88 symptomatic response
89 synchronous chemoradiation
90 systemic chemotherapy
91 systemic fluorouracil
92 tenesmus
93 tumor regression
94 tumor response
95 tumors
96 venous infusion
97 week 13
98 weeks
99 years
100 schema:name Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer
101 schema:pagination 1017-1024
102 schema:productId N06e02064104843ce909b393ffbb4d04f
103 Na1cc8f5ff1e34e949076c1c9d3201bfa
104 Nb45b565ed65943e9869c841e4f3b4199
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004258740
106 https://doi.org/10.1038/sj.bjc.6600822
107 schema:sdDatePublished 2022-10-01T06:32
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N854b665168bf407db7715047481acc46
110 schema:url https://doi.org/10.1038/sj.bjc.6600822
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N06e02064104843ce909b393ffbb4d04f schema:name doi
115 schema:value 10.1038/sj.bjc.6600822
116 rdf:type schema:PropertyValue
117 N087cb819152f4097ac6b16b0a6003757 rdf:first sg:person.0753037103.30
118 rdf:rest N9029ac09a7064ba2a6275b212c391de6
119 N14cd41371d8646498972c377c219a668 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Fluorouracil
121 rdf:type schema:DefinedTerm
122 N1f4b51c08ca6486ea08ee287c44a30b4 schema:issueNumber 7
123 rdf:type schema:PublicationIssue
124 N269fa8d4fdca4243b231c478e8bc2b66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Combined Modality Therapy
126 rdf:type schema:DefinedTerm
127 N2c63c993c656407db80f8e68eac4427b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 N2f462519aec042a184c8fb359d3a3b74 rdf:first sg:person.0624374163.59
131 rdf:rest Nddb9be33be6e47a7a933aeb294e9b52a
132 N34701f2063844b0e98ad3254fb3ca370 schema:affiliation grid-institutes:grid.424926.f
133 schema:familyName Rhodes
134 schema:givenName A
135 rdf:type schema:Person
136 N3c40012927a643b09d831fc5d53fad22 rdf:first sg:person.012011726757.20
137 rdf:rest N7f148329715f4c3d9fdb3cbc93ec0e95
138 N5444782eba4e470e8a76d24f79eed09d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Antineoplastic Combined Chemotherapy Protocols
140 rdf:type schema:DefinedTerm
141 N63065a6af42b4cf6ab501233d9dfd93d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Mitomycin
143 rdf:type schema:DefinedTerm
144 N7954a039fbf64a649a662cad66a29665 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Aged, 80 and over
146 rdf:type schema:DefinedTerm
147 N7f148329715f4c3d9fdb3cbc93ec0e95 rdf:first sg:person.01027613160.71
148 rdf:rest N2f462519aec042a184c8fb359d3a3b74
149 N80019e3947d344a98baa5f22fc531fb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Postoperative Complications
151 rdf:type schema:DefinedTerm
152 N854b665168bf407db7715047481acc46 schema:name Springer Nature - SN SciGraph project
153 rdf:type schema:Organization
154 N8e2295c9216849a5b4390774efa941d1 rdf:first sg:person.01054213150.25
155 rdf:rest Nde64362656dd4ce59d3657474aa2f6ad
156 N9029ac09a7064ba2a6275b212c391de6 rdf:first sg:person.01265153477.71
157 rdf:rest Na327a34359244641b7a722f376f361d4
158 N90f65507bfeb430d8e944ceb36f9396d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Adult
160 rdf:type schema:DefinedTerm
161 N9a24a9b894e24079b84e7a5a6a032279 rdf:first sg:person.0701422002.31
162 rdf:rest Nfc0a144adc7342fc94833988ff23071c
163 N9a85e1a51be0413a9c002e046a25d24e rdf:first sg:person.01035560774.45
164 rdf:rest N8e2295c9216849a5b4390774efa941d1
165 Na1cc8f5ff1e34e949076c1c9d3201bfa schema:name dimensions_id
166 schema:value pub.1004258740
167 rdf:type schema:PropertyValue
168 Na327a34359244641b7a722f376f361d4 rdf:first sg:person.01277776673.93
169 rdf:rest N9a24a9b894e24079b84e7a5a6a032279
170 Na5add7ffa0ac44c88dfb2f0a1d8fafcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Rectal Neoplasms
172 rdf:type schema:DefinedTerm
173 Nb255dedd05d745d8bbdf8d27a2e56cbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Chemotherapy, Adjuvant
175 rdf:type schema:DefinedTerm
176 Nb45b565ed65943e9869c841e4f3b4199 schema:name pubmed_id
177 schema:value 12671697
178 rdf:type schema:PropertyValue
179 Nb645f67b69cb4a958b647e187ea3471d schema:volumeNumber 88
180 rdf:type schema:PublicationVolume
181 Nc70a1bf14c7f4659ba6529db5f1e39f4 rdf:first sg:person.01000107664.44
182 rdf:rest N3c40012927a643b09d831fc5d53fad22
183 Nc75a32a4d4ee4773801c4bdbd1e89743 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Middle Aged
185 rdf:type schema:DefinedTerm
186 Nd62abebd96e54df5a9e20d7b453f4967 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Female
188 rdf:type schema:DefinedTerm
189 Nddb9be33be6e47a7a933aeb294e9b52a rdf:first sg:person.01332431220.96
190 rdf:rest rdf:nil
191 Nde64362656dd4ce59d3657474aa2f6ad rdf:first sg:person.01320161130.16
192 rdf:rest N087cb819152f4097ac6b16b0a6003757
193 Nead7f75c7a93415d80e31c2bc1cc0b98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Male
195 rdf:type schema:DefinedTerm
196 Nfa15daaf626b4430b7b9265e1e6c1d60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Aged
198 rdf:type schema:DefinedTerm
199 Nfc0a144adc7342fc94833988ff23071c rdf:first N34701f2063844b0e98ad3254fb3ca370
200 rdf:rest Nc70a1bf14c7f4659ba6529db5f1e39f4
201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
202 schema:name Medical and Health Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
205 schema:name Oncology and Carcinogenesis
206 rdf:type schema:DefinedTerm
207 sg:journal.1017082 schema:issn 0007-0920
208 1532-1827
209 schema:name British Journal of Cancer
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01000107664.44 schema:affiliation grid-institutes:grid.424926.f
213 schema:familyName Wotherspoon
214 schema:givenName A
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000107664.44
216 rdf:type schema:Person
217 sg:person.01027613160.71 schema:affiliation grid-institutes:grid.424926.f
218 schema:familyName Hill
219 schema:givenName A
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027613160.71
221 rdf:type schema:Person
222 sg:person.01035560774.45 schema:affiliation grid-institutes:grid.424926.f
223 schema:familyName Chau
224 schema:givenName I
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035560774.45
226 rdf:type schema:Person
227 sg:person.01054213150.25 schema:affiliation grid-institutes:grid.424926.f
228 schema:familyName Allen
229 schema:givenName M
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054213150.25
231 rdf:type schema:Person
232 sg:person.012011726757.20 schema:affiliation grid-institutes:grid.424926.f
233 schema:familyName Norman
234 schema:givenName A R
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011726757.20
236 rdf:type schema:Person
237 sg:person.01265153477.71 schema:affiliation grid-institutes:grid.424926.f
238 schema:familyName Brown
239 schema:givenName G
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265153477.71
241 rdf:type schema:Person
242 sg:person.01277776673.93 schema:affiliation grid-institutes:grid.424926.f
243 schema:familyName Hill
244 schema:givenName M
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277776673.93
246 rdf:type schema:Person
247 sg:person.01320161130.16 schema:affiliation grid-institutes:grid.424926.f
248 schema:familyName Cunningham
249 schema:givenName D
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16
251 rdf:type schema:Person
252 sg:person.01332431220.96 schema:affiliation grid-institutes:grid.424926.f
253 schema:familyName Prior
254 schema:givenName Y
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332431220.96
256 rdf:type schema:Person
257 sg:person.0624374163.59 schema:affiliation grid-institutes:grid.424926.f
258 schema:familyName Massey
259 schema:givenName A
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624374163.59
261 rdf:type schema:Person
262 sg:person.0701422002.31 schema:affiliation grid-institutes:grid.424926.f
263 schema:familyName Sumpter
264 schema:givenName K
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701422002.31
266 rdf:type schema:Person
267 sg:person.0753037103.30 schema:affiliation grid-institutes:grid.424926.f
268 schema:familyName Tait
269 schema:givenName D
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30
271 rdf:type schema:Person
272 sg:pub.10.1007/pl00002396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021451694
273 https://doi.org/10.1007/pl00002396
274 rdf:type schema:CreativeWork
275 sg:pub.10.1007/s000660050051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043048801
276 https://doi.org/10.1007/s000660050051
277 rdf:type schema:CreativeWork
278 grid-institutes:grid.424926.f schema:alternateName Department of Computing, Royal Marsden Hospital, London Surrey, UK
279 Department of Diagnostic Imaging, Royal Marsden Hospital, London Surrey, UK
280 Department of Histopathology, Royal Marsden Hospital, London Surrey, UK
281 Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
282 Department of Radiotherapy, Royal Marsden Hospital, London Surrey, UK
283 schema:name Department of Computing, Royal Marsden Hospital, London Surrey, UK
284 Department of Diagnostic Imaging, Royal Marsden Hospital, London Surrey, UK
285 Department of Histopathology, Royal Marsden Hospital, London Surrey, UK
286 Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
287 Department of Radiotherapy, Royal Marsden Hospital, London Surrey, UK
288 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...